...
首页> 外文期刊>Tissue antigens. >A comprehensive guide to antibody and T-cell responses in type 1 diabetes.
【24h】

A comprehensive guide to antibody and T-cell responses in type 1 diabetes.

机译:关于1型糖尿病的抗体和T细胞反应的全面指南。

获取原文
获取原文并翻译 | 示例
           

摘要

Type 1 diabetes (T1D) is an organ-specific autoimmune disease in which the insulin-producing beta cells in the pancreatic islets are selectively eliminated. T cells specific for beta-cell antigens are the mediators of this precise cellular destruction. However, antibodies to beta-cell proteins are also generated and may be used for predicting disease in at-risk populations. Over the past two decades, numerous beta-cell proteins and lipids have been implicated as autoantigens in patients or in non-obese diabetic (NOD) mice, a well-studied animal model of T1D. Here, we present a review of these antigens, accompanied by their T-cell epitopes, where known, and a discussion of our current understanding of why particular self-proteins become disease-inciting antigens. Although two dozen beta-cell antigens have been identified to date, few of these have been confirmed to be recognized by pathogenic T cells early in the disease process. Further identification and characterization of initiating beta-cell antigens targeted by pathogenic T cells should be a priority for future studies.
机译:1型糖尿病(T1D)是一种器官特异性自身免疫性疾病,其中胰岛中产生胰岛素的β细胞被选择性清除。对β细胞抗原具有特异性的T细胞是这种精确细胞破坏的介体。但是,还会生成针对β细胞蛋白的抗体,并可用于预测高危人群的疾病。在过去的二十年中,患者或非肥胖型糖尿病(NOD)小鼠(一种经过充分研究的T1D动物模型)已被暗示许多β细胞蛋白和脂质作为自身抗原。在这里,我们对这些抗原进行了综述,并附有已知的T细胞表位,并讨论了我们目前对特定自身蛋白为何会引起疾病的抗原的理解。尽管迄今为止已经鉴定出了十二种β细胞抗原,但在疾病过程的早期阶段,已经确认了其中很少几种被病原性T细胞识别。病原性T细胞靶向的起始β细胞抗原的进一步鉴定和表征应是未来研究的重点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号